---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-089579"
form_type: "8-K"
ticker: "SGMT"
cik: "0001400118"
company_name: "Sagimet Biosciences Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T16:59:48.315946+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Sagimet posts updated investor presentation on NASH, acne, cancer pipeline

## Summary
- Company furnished investor slide deck dated August 10, 2023; no financial results disclosed.
- Presentation focuses on novel therapies targeting metabolic dysfunction for NASH, acne, and cancer.
- No quantitative updates (e.g., clinical data, revenue, guidance) provided in filing or exhibit.

## SEC filing metadata
- accession: 0001104659-23-089579
- form_type: 8-K
- ticker: SGMT
- cik: 0001400118
- company_name: Sagimet Biosciences Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1400118/000110465923089579/0001104659-23-089579-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1400118/000110465923089579/tm2323360d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-089579
- JSON: https://secwatch.observer/filing/0001104659-23-089579.json
- Plain text: https://secwatch.observer/filing/0001104659-23-089579.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.